Evidence of Treatment Benefits in Patients with Mucopolysaccharidosis Type I-Hurler in Long-term Follow-up Using a New Magnetic Resonance Imaging Scoring System
- 18 September 2021
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 240, 297-301.e5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedureOrphanet Journal of Rare Diseases, 2011
- Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapyJournal of Inherited Metabolic Disease, 2011
- Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and IIMolecular Genetics and Metabolism, 2009
- Metachromatic Leukodystrophy: A Scoring System for Brain MR Imaging ObservationsAmerican Journal of Neuroradiology, 2009
- Mucopolysaccharidosis I: Management and Treatment GuidelinesPediatrics, 2009
- The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UKOrphanet Journal of Rare Diseases, 2008
- Metachromatic leukodystrophy – mutation analysis provides further evidence of genotype–phenotype correlationClinical Genetics, 2008
- Brain MRI in mucopolysaccharidosisNeurology, 2007
- Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot studyDevelopmental Medicine & Child Neurology, 2007
- Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidosesAmerican Journal of Medical Genetics Part A, 2003